A detailed history of Becker Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Becker Capital Management Inc holds 953,123 shares of PFE stock, worth $24.6 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
953,123
Previous 963,763 1.1%
Holding current value
$24.6 Million
Previous $27 Million 2.29%
% of portfolio
0.91%
Previous 0.93%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$27.7 - $31.39 $294,728 - $333,989
-10,640 Reduced 1.1%
953,123 $27.6 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $854,242 - $1 Million
-33,818 Reduced 3.39%
963,763 $27 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $417,165 - $479,039
16,113 Added 1.64%
997,581 $27.7 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.69 Million - $2.2 Million
64,689 Added 7.06%
981,468 $28.3 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $1.31 Million - $1.54 Million
-40,976 Reduced 4.28%
916,779 $30.4 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $2.61 Million - $3.02 Million
72,328 Added 8.17%
957,755 $35.1 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $1.46 Million - $1.9 Million
37,020 Added 4.36%
885,427 $36.1 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $180,735 - $235,930
4,329 Added 0.51%
848,407 $43.5 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $603,669 - $736,928
-13,795 Reduced 1.61%
844,078 $36.9 Million
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $1.16 Million - $1.38 Million
-25,008 Reduced 2.83%
857,873 $45 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $460,885 - $571,095
-10,074 Reduced 1.13%
882,881 $45.7 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $1.11 Million - $1.65 Million
-26,861 Reduced 2.92%
892,955 $52.7 Million
Q3 2021

Oct 14, 2021

SELL
$39.25 - $50.42 $2.22 Million - $2.85 Million
-56,579 Reduced 5.79%
919,816 $39.6 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $375,977 - $425,919
10,470 Added 1.08%
976,395 $38.2 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $439,221 - $495,353
13,115 Added 1.38%
965,925 $35 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $894,318 - $1.14 Million
-26,720 Reduced 2.73%
952,810 $35.1 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $760,857 - $892,659
-23,964 Reduced 2.39%
979,530 $35.9 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $3.57 Million - $4.34 Million
-118,655 Reduced 10.57%
1,003,494 $32.8 Million
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $4.9 Million - $7 Million
-181,168 Reduced 13.9%
1,122,149 $36.6 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $196,631 - $223,151
5,973 Added 0.46%
1,303,317 $51.1 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $1.23 Million - $1.6 Million
-37,911 Reduced 2.84%
1,297,344 $46.6 Million
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $80,061 - $89,890
2,165 Added 0.16%
1,335,255 $57.8 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $4.47 Million - $4.91 Million
-119,161 Reduced 8.21%
1,333,090 $56.6 Million
Q4 2018

Feb 04, 2019

SELL
$38.47 - $43.86 $4.75 Million - $5.42 Million
-123,530 Reduced 7.84%
1,452,251 $63.4 Million
Q3 2018

Nov 05, 2018

SELL
$34.47 - $41.81 $1.56 Million - $1.89 Million
-45,235 Reduced 2.79%
1,575,781 $69.4 Million
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $1.19 Million - $1.26 Million
35,974 Added 2.27%
1,621,016 $58.8 Million
Q1 2018

May 07, 2018

BUY
$31.91 - $37.02 $2.87 Million - $3.33 Million
90,068 Added 6.02%
1,585,042 $56.3 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $469,065 - $497,694
-14,103 Reduced 0.93%
1,494,974 $54.1 Million
Q3 2017

Nov 02, 2017

BUY
$31.0 - $34.15 $680,419 - $749,558
21,949 Added 1.48%
1,509,077 $53.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,487,128
1,487,128 $50 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.